Suppr超能文献

临床矮小儿童中生长激素水平较高。

High growth hormone levels in clinically short stature children.

作者信息

Awan Tariq Mahmood, Sattar Abdus, Khattak Ihsan Gul

机构信息

Department of Chemical Pathology, Army Medical College, Rawalpindi.

出版信息

J Ayub Med Coll Abbottabad. 2006 Apr-Jun;18(2):29-33.

Abstract

BACKGROUND

Growth Hormone (GH) is secreted from the anterior pituitary gland. It binds to receptors on the surface of target cells, stimulates production of Insulin-like growth factor-I (IGF-I) leading to growth of almost all tissues of the body capable of growing. Growth failure (height below 3rd centile) occurs in children who do not secrete sufficient amount of GH. In some children, however, short stature is present in the presence of high levels of GH in their blood and they also secrete normal to increased amounts of GH in response to stimulation tests when tested for possible deficiency of GH. This condition is known as GH resistance syndrome or Larons syndrome (LS).

METHODS

All patients after a thorough clinical evaluation underwent GH evaluation protocol as follows. On arrival in the lab a blood sample was collected for basal GH level in each patient. Screening was performed by subjecting the patients to exercise stimulation test and/or L-dopa stimulation test. Patients with GH deficiency underwent insulin tolerance test (ITT) after one week for confirmation. All the basal and post-stimulation samples were analyzed for GH levels. A level below 10mIU/L indicated GH deficiency, between 10-20mIU/L as borderline and an adequate response was defined as a GH >20mIU/L. Patients with a basal GH level of >20mIU/L and/or a post-stimulation level of >40mIU/L were arbitrarily considered as having exaggerated GH levels. This article evaluates the high plasma growth hormone levels among clinically short stature children undergoing growth hormone stimulation tests.

RESULTS

Two hundred ninty-three patients reported for GH evaluation. Twenty were excluded for various reasons. Thus 273 patients were included for GH evaluation out of which 66(24.2%) showed GH deficiency, 89(32.6%) were borderline while 118(43.2%) patients exhibited adequate response, with GH levels of >20mIU/L. A number of patients unexpectedly showed very high GH levels on screening tests. Out of 118 patients, 21 showed either very high basal levels of >20mIU/L and/or a much-exaggerated response to stimulation tests with levels more than about 40mIU/L. Close consanguinity was found in 67% of patients showing very high GH levels.

CONCLUSION

Some children with idiopathic short stature may show high levels of GH during their evaluation for GH deficiency. We identified a considerable number of such patients. These patients require further investigations.

摘要

背景

生长激素(GH)由垂体前叶分泌。它与靶细胞表面的受体结合,刺激胰岛素样生长因子-I(IGF-I)的产生,从而导致身体几乎所有能够生长的组织生长。生长激素分泌不足的儿童会出现生长发育迟缓(身高低于第3百分位数)。然而,在一些儿童中,尽管血液中生长激素水平较高,但仍存在身材矮小的情况,并且在接受生长激素缺乏可能性检测时,他们对刺激试验的反应显示生长激素分泌正常或增加。这种情况被称为生长激素抵抗综合征或拉龙综合征(LS)。

方法

所有患者在经过全面临床评估后,按照以下生长激素评估方案进行检查。患者到达实验室后,采集血样检测基础生长激素水平。通过让患者进行运动刺激试验和/或左旋多巴刺激试验进行筛查。生长激素缺乏的患者在一周后接受胰岛素耐量试验(ITT)以确诊。对所有基础和刺激后样本进行生长激素水平分析。生长激素水平低于10mIU/L表明生长激素缺乏,10 - 20mIU/L为临界值,生长激素水平>20mIU/L被定义为反应良好。基础生长激素水平>20mIU/L和/或刺激后水平>40mIU/L的患者被随意认为生长激素水平过高。本文评估了接受生长激素刺激试验的临床身材矮小儿童中血浆生长激素水平过高的情况。

结果

293名患者前来进行生长激素评估。20名因各种原因被排除。因此,273名患者被纳入生长激素评估,其中66名(24.2%)显示生长激素缺乏,89名(32.6%)为临界值,118名(43.2%)患者反应良好,生长激素水平>20mIU/L。一些患者在筛查试验中意外显示出非常高的生长激素水平。在118名患者中,21名显示基础水平>20mIU/L或对刺激试验反应过度,水平超过约40mIU/L。在生长激素水平非常高的患者中,67%发现有近亲关系。

结论

一些特发性身材矮小的儿童在评估生长激素缺乏时可能显示出生长激素水平过高。我们发现了相当数量的此类患者。这些患者需要进一步检查。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验